This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Dec;6(6):447-58.

Cost of hypertension treatment and the price of health

J Menard¹, P Cornu, M Day

Affiliations

PMID: 1296008

Review

Cost of hypertension treatment and the price of health

J Menard et al. J Hum Hypertens. 1992 Dec.

. 1992 Dec;6(6):447-58.

Authors

J Menard¹, P Cornu, M Day

Affiliation

¹ Centre de Médecine Préventive Cardiovasculaire, Hôpital Broussais, Paris, France.

PMID: 1296008

No abstract available

PubMed Disclaimer

Similar articles

Cost effective analyses in the treatment of high blood pressure.
Fletcher A. Fletcher A. J Hum Hypertens. 1992 Dec;6(6):437-45. J Hum Hypertens. 1992. PMID: 1296007 Review. No abstract available.
[A reply on subsidizing of antihypertensive agents: the problem is exceptional undertreatment of hypertension].
Willenheimer R, Nyström F, Berggren B, Lindström T, Cizinsky S, Weiss L. Willenheimer R, et al. Lakartidningen. 2008 Oct 22-28;105(43):3055-6. Lakartidningen. 2008. PMID: 19024623 Swedish. No abstract available.
Relative costs of antihypertensive drug treatment.
Strasser T. Strasser T. J Hum Hypertens. 1992 Dec;6(6):489-94. J Hum Hypertens. 1992. PMID: 1296015 Review. No abstract available.
Angiotensin receptor blockers: impact on costs of care.
[No authors listed] [No authors listed] Am J Manag Care. 2005 Nov;11(13 Suppl):S400-3. Am J Manag Care. 2005. PMID: 16300456 Review.
[The pharmaco-economics of the treatment of arterial hypertension: data and controversies].
Rorive G, Delporte JP. Rorive G, et al. Bull Mem Acad R Med Belg. 1998;153(7-9):317-21; discussion 322-4. Bull Mem Acad R Med Belg. 1998. PMID: 10100395 French.

See all similar articles

Cited by

Pharmacoeconomic considerations in the management of hypertension.
Pardell H, Tresserras R, Armario P, Hernández del Rey R. Pardell H, et al. Drugs. 2000;59 Suppl 2:13-20; discussion 39-40. doi: 10.2165/00003495-200059002-00002. Drugs. 2000. PMID: 10678593 Review.
Noncompliance with antihypertensive therapy. Economic consequences.
Skaer TL, Sclar DA, Robison LM. Skaer TL, et al. Pharmacoeconomics. 1996 Jan;9(1):1-4. doi: 10.2165/00019053-199609010-00001. Pharmacoeconomics. 1996. PMID: 10160083 Review. No abstract available.
Pharmacoeconomic burden of undertreating hypertension.
Degli Esposti L, Valpiani G. Degli Esposti L, et al. Pharmacoeconomics. 2004;22(14):907-28. doi: 10.2165/00019053-200422140-00002. Pharmacoeconomics. 2004. PMID: 15362928 Review.
Economics of hypertension control. World Hypertension League.
[No authors listed] [No authors listed] Bull World Health Organ. 1995;73(4):417-24. Bull World Health Organ. 1995. PMID: 7554012 Free PMC article. Review.
[Pathogenesis and epidemiology of arterial hypertension].
Pardell H, Armario P, Hernández R. Pardell H, et al. Drugs. 1998;56 Suppl 2:1-10. doi: 10.2165/00003495-199856002-00001. Drugs. 1998. PMID: 9813737 Review. French.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information